Children and youth are at virtually no risk of dying from COVID-19 or transmitting it to others, but deaths and injuries to children and youth have already occurred in the COVID-19 injection clinical trials.
Preliminary findings from two vaccine safety monitoring systems suggest a higher-than-expected number of cases of heart inflammation after the second dose of mRNA COVID-19 vaccines in 16 to 24 year olds, the U.S. Centers for Disease Control and Prevention said on Thursday.
More than half of the myocarditis or pericarditis cases reported to the U.S. Vaccine Adverse Event Reporting System after patients had received either the Pfizer/BioNTech or Moderna vaccines were in people between the ages of 12 and 24, the CDC said. Those age groups accounted for less that 9% of the doses administered. Read more.
At Least 18 Cases of Apparent Heart Problems in Young People in CT After COVID-19 Vaccine
At least 18 teens and young adults in Connecticut have shown symptoms of heart problems after receiving the COVID-19 vaccine, acting health commissioner Dr. Deirdre Gifford said Monday.
Gifford said all but one of the young adults hospitalized for signs of heart problems have been released. Four of those young residents were hospitalized at Yale New Haven Health and three at Connecticut Children’s.
Extremely dangerous inflammation of the heart as a result of mRNA shots. 1:2500 affected. Higher rates after 2nd dose and within the first 7 days of that dose. December 21st 2020 documents prove FDA and CDC knew the risks to younger people.